S Y Bögli1,2, D Utebay1, N Smits1, L P Westphal1, L Hirsbrunner1, S Unseld1, E Keller1,3, G Brandi4. 1. Institute for Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland. 2. Department of Neurology, University Hospital Zurich, Zurich, Switzerland. 3. Department of Neurosurgery and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland. 4. Institute for Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland. Giovanna.brandi@usz.ch.
Abstract
BACKGROUND: Sex-related differences in patients with aneurysmal subarachnoid hemorrhage (aSAH) exist. More females than males are affected. Aneurysm location is associated to sex. The relationship between sex and outcome, however, is unclear. Possible differences in management might influence the occurrence of primary and secondary brain injury and thus outcome. The study compares demographics, intensity of treatment, complications, and outcome among females and males with aSAH. METHODS: All consecutive patients with aSAH admitted to the neurocritical care unit, University Hospital Zurich over a 5-year period were eligible in this retrospective study. Patients' characteristics, comorbidities, aSAH severity, frequency of vasospasm/delayed cerebral ischemia, frequency of invasive interventions, and 3-month outcome were compared by sex. Univariate analysis was performed with the data dichotomized by sex, and outcome. Multivariate analysis for prediction of outcomes was performed. RESULTS: Three hundred forty-eight patients were enrolled (64% females). Women were older than men. Comorbidities, scores at admission, and treatment modality were comparable among males and females. Vasospasm and DCI occurred similarly among females and males. Interventions and frequency of intraarterial spasmolysis were comparable between sexes. In the multivariate analysis, increasing age, female sex, increasing comorbidities, WFNS and Fisher grade, and presence of delayed cerebral ischemia were predictors of unfavorable outcome when considering all patients. However, after excluding death as a possible outcome, sex did not remain a predictor of unfavorable outcome. CONCLUSIONS: In the study population, women with aSAH might have present a worse outcome at 3 months. However, no differences by sex that might explain this difference were found in intensity of treatment and management.
BACKGROUND: Sex-related differences in patients with aneurysmal subarachnoid hemorrhage (aSAH) exist. More females than males are affected. Aneurysm location is associated to sex. The relationship between sex and outcome, however, is unclear. Possible differences in management might influence the occurrence of primary and secondary brain injury and thus outcome. The study compares demographics, intensity of treatment, complications, and outcome among females and males with aSAH. METHODS: All consecutive patients with aSAH admitted to the neurocritical care unit, University Hospital Zurich over a 5-year period were eligible in this retrospective study. Patients' characteristics, comorbidities, aSAH severity, frequency of vasospasm/delayed cerebral ischemia, frequency of invasive interventions, and 3-month outcome were compared by sex. Univariate analysis was performed with the data dichotomized by sex, and outcome. Multivariate analysis for prediction of outcomes was performed. RESULTS: Three hundred forty-eight patients were enrolled (64% females). Women were older than men. Comorbidities, scores at admission, and treatment modality were comparable among males and females. Vasospasm and DCI occurred similarly among females and males. Interventions and frequency of intraarterial spasmolysis were comparable between sexes. In the multivariate analysis, increasing age, female sex, increasing comorbidities, WFNS and Fisher grade, and presence of delayed cerebral ischemia were predictors of unfavorable outcome when considering all patients. However, after excluding death as a possible outcome, sex did not remain a predictor of unfavorable outcome. CONCLUSIONS: In the study population, women with aSAH might have present a worse outcome at 3 months. However, no differences by sex that might explain this difference were found in intensity of treatment and management.
Authors: Carma Ayala; Janet B Croft; Kurt J Greenlund; Nora L Keenan; Ralph S Donehoo; Ann M Malarcher; George A Mensah Journal: Stroke Date: 2002-05 Impact factor: 7.914
Authors: Valery L Feigin; Gabriel J E Rinkel; Carlene M M Lawes; Ale Algra; Derrick A Bennett; Jan van Gijn; Craig S Anderson Journal: Stroke Date: 2005-11-10 Impact factor: 7.914
Authors: E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa Journal: Stroke Date: 2012-05-03 Impact factor: 7.914
Authors: Elizabeth A Crago; Paula R Sherwood; Catherine Bender; Jeffrey Balzer; Dianxu Ren; Samuel M Poloyac Journal: Biol Res Nurs Date: 2014-12-29 Impact factor: 2.522
Authors: Gian Marco De Marchis; Chris Schaad; Christian Fung; Juergen Beck; Jan Gralla; Jukka Takala; Stephan M Jakob Journal: Clin Neurol Neurosurg Date: 2017-04-06 Impact factor: 1.876
Authors: Meike W Vernooij; Bob Roozenbeek; Tim Y Cras; Daniel Bos; M Arfan Ikram; Mervyn D I Vergouwen; Diederik W J Dippel; Trudy Voortman; Hieab H H Adams Journal: Stroke Date: 2020-06-10 Impact factor: 7.914